Growth Metrics

Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Q3 2025 value amounting to $2.7 million.

  • Acadia Pharmaceuticals' Amortizatization of Intangibles rose 1616.89% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 1191.93%. This contributed to the annual value of $15.0 million for FY2024, which is 9863.27% up from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Amortizatization of Intangibles of $2.7 million as of Q3 2025, which was up 1616.89% from $2.7 million recorded in Q2 2025.
  • Acadia Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $5.3 million during Q1 2024, with a 5-year trough of -$689000.0 in Q1 2021.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $2.0 million (2023), whereas its average is $1.7 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Amortizatization of Intangibles plummeted by 27225.0% in 2021 and then surged by 159100.0% in 2023.
  • Quarter analysis of 5 years shows Acadia Pharmaceuticals' Amortizatization of Intangibles stood at -$638000.0 in 2021, then soared by 428.21% to $2.1 million in 2022, then dropped by 15.04% to $1.8 million in 2023, then surged by 180.38% to $5.0 million in 2024, then crashed by 45.41% to $2.7 million in 2025.
  • Its Amortizatization of Intangibles was $2.7 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.7 million in Q1 2025.